AAPL   329.23 (+2.14%)
MSFT   185.75 (+1.55%)
FB   230.62 (+1.91%)
AMZN   2,468.73 (+0.33%)
NVDA   354.61 (+1.13%)
BABA   220.01 (+0.90%)
MU   54.21 (+5.84%)
GE   8.22 (+6.07%)
AMD   52.54 (-0.17%)
T   32.87 (+3.37%)
ACB   13.84 (-2.74%)
F   7.41 (+12.80%)
NFLX   414.24 (-0.02%)
BAC   28.41 (+6.05%)
BA   215.73 (+17.05%)
AAPL   329.23 (+2.14%)
MSFT   185.75 (+1.55%)
FB   230.62 (+1.91%)
AMZN   2,468.73 (+0.33%)
NVDA   354.61 (+1.13%)
BABA   220.01 (+0.90%)
MU   54.21 (+5.84%)
GE   8.22 (+6.07%)
AMD   52.54 (-0.17%)
T   32.87 (+3.37%)
ACB   13.84 (-2.74%)
F   7.41 (+12.80%)
NFLX   414.24 (-0.02%)
BAC   28.41 (+6.05%)
BA   215.73 (+17.05%)
AAPL   329.23 (+2.14%)
MSFT   185.75 (+1.55%)
FB   230.62 (+1.91%)
AMZN   2,468.73 (+0.33%)
NVDA   354.61 (+1.13%)
BABA   220.01 (+0.90%)
MU   54.21 (+5.84%)
GE   8.22 (+6.07%)
AMD   52.54 (-0.17%)
T   32.87 (+3.37%)
ACB   13.84 (-2.74%)
F   7.41 (+12.80%)
NFLX   414.24 (-0.02%)
BAC   28.41 (+6.05%)
BA   215.73 (+17.05%)
AAPL   329.23 (+2.14%)
MSFT   185.75 (+1.55%)
FB   230.62 (+1.91%)
AMZN   2,468.73 (+0.33%)
NVDA   354.61 (+1.13%)
BABA   220.01 (+0.90%)
MU   54.21 (+5.84%)
GE   8.22 (+6.07%)
AMD   52.54 (-0.17%)
T   32.87 (+3.37%)
ACB   13.84 (-2.74%)
F   7.41 (+12.80%)
NFLX   414.24 (-0.02%)
BAC   28.41 (+6.05%)
BA   215.73 (+17.05%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 MediciNovaEvelo BiosciencesHumanigenCerecorAeglea Bio Therapeutics
SymbolNASDAQ:MNOVNASDAQ:EVLOOTCMKTS:HGENNASDAQ:CERCNASDAQ:AGLE
Price Information
Current Price$5.37$4.16$2.82$2.84$9.56
52 Week RangeBuyHoldN/ABuyBuy
Beat the Market™ Rank
Overall Score1.81.60.52.42.1
Analysis Score3.53.20.03.43.5
Community Score2.72.42.52.92.8
Dividend Score0.00.00.00.00.0
Ownership Score3.02.00.05.04.0
Earnings & Valuation Score0.00.60.00.60.0
Analyst Ratings
Consensus RecommendationBuyHoldN/ABuyBuy
Consensus Price Target$11.00$11.67N/A$10.50$13.33
% Upside from Price Target104.84% upside180.45% upsideN/A269.72% upside39.47% upside
Trade Information
Market Cap$239.73 million$132.88 million$369.10 million$170.59 million$408.47 million
Beta1.710.98-1.581.882.08
Average Volume94,13787,654106,506364,972226,650
Sales & Book Value
Annual RevenueN/AN/AN/A$6.75 million$3.89 million
Price / SalesN/AN/AN/A25.08109.58
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.71 per share$1.88 per share($0.13) per share$0.40 per share$2.07 per share
Price / BookN/AN/AN/A7.104.62
Profitability
Net Income$-12,940,000.00$-85,470,000.00$-10,290,000.00$-16,070,000.00$-78,250,000.00
EPSN/A($2.67)N/A($0.30)($2.45)
Trailing P/E Ratio0.00N/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)-14.83%-125.94%N/A-68.23%-113.09%
Return on Assets (ROA)-14.07%-85.77%-1,303.57%-28.57%-87.34%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.50%N/AN/A0.11%
Current Ratio34.63%4.89%0.02%1.66%3.17%
Quick Ratio34.63%4.89%0.02%1.66%3.17%
Ownership Information
Institutional Ownership Percentage21.80%85.24%N/A59.90%46.09%
Insider Ownership Percentage15.30%59.10%7.10%64.30%12.60%
Miscellaneous
Employees97536461
Shares Outstanding44.07 million32.33 million126.40 million59.61 million44.59 million
Next Earnings Date7/23/2020 (Estimated)8/4/2020 (Estimated)8/10/2020 (Estimated)8/13/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.